Anthony C. Nichols
Papers
14
Total Citations
1,083
H-Index
9
About
Dr. Anthony C. Nichols is a leading head and neck surgical oncologist whose research has fundamentally shaped the debate between surgical and non-surgical treatments for oropharyngeal cancer. His primary research areas include transoral robotic surgery (TORS), radiotherapy, and the management of HPV-related oropharyngeal squamous cell carcinoma (OPSCC). Dr. Nichols is best known as the principal investigator of the landmark ORATOR trials, a series of randomized phase II studies comparing TORS with neck dissection against primary radiotherapy. The initial ORATOR trial (2019), cited over 458 times, provided critical early evidence on quality-of-life outcomes between these two modalities, while the final results (2024) offered definitive long-term data. His systematic reviews and comprehensive analyses have established evidence-based frameworks for treatment selection in early-stage OPSCC and supraglottic cancer. Beyond clinical trials, Dr. Nichols has contributed to translational research, including high-throughput drug testing in HPV-positive and negative cell lines. His work has been instrumental in guiding clinical decision-making for the rapidly rising number of HPV-related oropharyngeal cancer patients, making him a pivotal figure in modern head and neck oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Transoral robotic total laryngectomy: Report of 3 cases73 citations · 2013
- 6
- 7
- 8
- 9
- 10